2 min read

KBI Biopharma Holds Ribbon Cutting for New Commercial Manufacturing Facility

3 min read

Oragenics Engages KBI Biopharma to Support Development of the Intranasal COVID-19 Vaccine Candidate NT-CoV2-1

3 min read

KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program

3 min read

Adalta Secures AD-214 Resupply Under KBI Biopharma MSA

2 min read

Selexis and KBI Biopharma Enter into Agreements with Immatics for Integrated Approach to Advance Immatics TCR Bispecific Program Towards IND

2 min read

KBI Biopharma Enters Commercial Manufacturing Agreement with AM-Pharma to Prepare for the Commercial Launch of Lead Program in Acute Kidney Disease

2 min read

Durham Tech and KBI BioPharma Partner to Boost Diversity and Create Life Sciences Job Opportunities for North Carolina Students and Veterans

1 min read

BioPharm International | Maximum Output Starts with Optimized Upstream Processing

2 min read

KBI Biopharma Expands US Operations With New $150 Million Commercial Manufacturing Facility Based In RTP, North Carolina

4 min read

JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities For Selexis And KBI Biopharma In Geneva, Switzerland